2021-01-11,Entera Bio Issues Letter to Shareholders
2020-12-10,Entera Bio Announces FDA Approval of IND Application for EB613  an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis
2020-12-01,"The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit"
2020-11-30,Entera Bio Appoints Spiros Jamas as Chief Executive Officer
2020-11-19,Entera Bio Ltd. to Host Earnings Call
2020-11-19,Entera Bio Ltd Announces Third Quarter 2020 Financial Results and Provides Clinical Update
2020-11-13,"Entera Bio to Report Third Quarter 2020 Business and Financial Results on November 19, 2020"
2020-11-09,Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In Osteoporosis
2020-11-02,Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
2020-09-10,Entera Bio to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-08-24,Here's Why We're Watching Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
2020-08-20,"The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics"
2020-08-20,Entera Bio Ltd Announces Interim Data From Phase 2 Clinical Trial of EB613 in Osteoporosis and Second Quarter 2020 Financial Results
2020-08-17,"Entera Bio to Report Second Quarter 2020 Business and Financial Results on August 20, 2020"
2020-08-10,Entera Bio Announces Management Changes
2020-08-05,Entera Bio to Present at BTIGs Virtual Biotechnology Conference
2020-07-23,"The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results"
2020-07-22,Entera Bio Ltd. Announces Highly Encouraging Oral PTH Market Survey Results
2020-07-07,Entera Bio Ltd Provides Update on Phase 2 Clinical Trial of EB613 in Postmenopausal Women With Osteoporosis
2020-05-21,Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results
2020-05-17,"The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows"
2020-05-07,"Entera Bio to Report Interim Data From EB613 Phase 2 Trial and First Quarter 2020 Business and Financial Results on May 21, 2020"
2020-03-26,"ENTERA BIO LTD ANNOUNCES FINANCIAL AND OPERATING RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019"
2020-03-26,Entera Bio Ltd. to Host Earnings Call
2020-03-16,"ENTERA BIO TO REPORT 2019 BUSINESS AND FINANCIAL RESULTS ON MARCH 26, 2020"
2020-02-04,Frost & Sullivan Releases Osteoporosis Drug Market Data
2019-12-18,Entera Bio Announces the Completion of $14.3 million Private Placement
2019-12-11,Entera Announces Closing of Private Placement
2019-11-21,Entera Bio Reports Third Quarter 2019 Financial Results and Provides Operating Update
2019-11-21,Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer
2019-11-18,We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
2019-11-07,"Entera Bio to Announce Third Quarter 2019 Financial Results on Thursday, November 21, 2019"
2019-10-07,Introducing Investors to Breakthrough Hi-tech and Bio-tech Companies: Frost & Sullivan Publishes Q2 Coverage for Investors to Make Informed Decisions
2019-09-23,Entera Bio Reports Positive Results from a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism
2019-09-19,Such Is Life: How Entera Bio (NASDAQ:ENTX) Shareholders Saw Their Shares Drop 51%
2019-09-19,Entera Bio to Present at the Ladenburg Thalmann 2019 Healthcare Conference
2019-08-20,Entera Bio Reports Second Quarter 2019 Financial Results and Provides Operating Update
2019-08-20,Entera Bio Ltd. to Host Earnings Call
2019-08-15,"Entera Bio to Announce Second Quarter and Six Months ended June 30, 2019 Financial Results on Tuesday, August 20, 2019"
2019-08-05,Entera Bio Appoints Adam Gridley as Chief Executive Officer
2019-07-11,What Type Of Shareholder Owns Entera Bio Ltd.'s (NASDAQ:ENTX)?
2019-07-02,Entera Announces Initiation of Phase 2 Dose Ranging Study for Oral PTH
2019-07-01,From Injections to Pills - Entera Bio (ENTX): Initiation of Coverage by Frost & Sullivan
2019-06-27,Entera Bio Reports First Quarter 2019 Financial Results and Operating Update
2019-03-28,Entera Bio Reports 2018 Annual Financial Results and Operating Update
2019-03-28,Entera Bio Announces 20-F Filing
2019-03-27,"Entera Bio to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Thursday, March 28"
2019-03-07,Entera Bio Announces a Transition in the Chief Financial Officer Position
2019-01-31,Entera Bio Announces Positive Feedback and Guidance from the US FDA Regarding its Development Plans for Oral PTH in Osteoporosis
2019-01-22,Entera Bio Reports Third Quarter 2018 Financial Results and Operating Update
2019-01-10,Entera Bio Appoints Gerald M. Ostrov to Board of Directors
2018-12-11,Entera shares jump 11.5% on news of collaboration with Amgen
2018-12-11,Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
2018-11-08,Entera Bio Reports Positive Results from Part 1 of a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism
2018-10-02,Entera Bio Appoints Two New External Independent Members to the Board of Directors
2018-09-21,Entera Bio Appoints Dr. Arthur Santora as Chief Medical Officer
2018-08-20,Entera Bio Reports Second Quarter 2018 Financial Results and Operating Update
2018-08-09,Entera Bio Ltd. Announces Appointment of Mr. Gerald Lieberman as Chairman of the Board of Directors
2018-08-01,Entera Bio Completes Part 1 of a Phase 2 PK/PD Study in Hypoparathyroidism Patients
2018-07-02,Entera Bio Ltd. Announces Closing of Initial Public Offering
2018-06-28,Entera Bio Ltd. Announces Pricing of Initial Public Offering
